Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ciprofol plus remifentanil for conscious sedation during comfortable oral therapy
ChiCTR2600131859Phase 2Completed
- Sponsor
- The Sixth Affiliated Hospital, South China University of Technology
- Start
- Mar 2026
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Allosteric Modulators → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of ciprofol and remifentanil in Dental anxiety and None, sponsored by The Sixth Affiliated Hospital, South China University of Technology. Primary endpoint: Sedation level reached a Modified Observer's Assessment of Alertness/Sedation score of 3-4. Started Mar 2026; status: completed.
02
Drugs
ciprofolremifentanil
03
Conditions
Dental anxiety
Beyond the preview
Go deeper on ChiCTR2600131859.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2600131859.